View ICR - OIRA Conclusion



0938-1051 201804-0938-018
Historical Active 201712-0938-001
HHS/CMS CM-CPC
Medicare Advantage and Prescription Drug Program: Final Marketing Provisions CFR 422.111(a)(3) and 423.128(a)(3) (CMS-10260)
Revision of a currently approved collection   No
Regular
Approved with change 12/03/2018
05/11/2018
Previous terms continue: Approval of this package is based on the understanding that the program staff will update appropriate OMB staff annually on any changes within the package. At the time of the briefing, OMB staff will determine if such changes are non-substantive or substantive.
  Inventory as of this Action Requested Previously Approved
12/31/2021 36 Months From Approved 05/31/2020
41,091 0 805
29,803 0 9,660
8,068,730,000 0 0